Randomized Study of Early Palliative Care Integrated With Standard Oncology Care Versus Standard Oncology Care Alone in Patients With Advanced Lung and Non-colorectal Gastrointestinal Malignancies
Subjects and their caregiver will complete a baseline questionnaire and then be randomized
to a study group.
Subjects who are randomized to Standard Oncology Care will follow up with their treating
oncologist. They will consult with the palliative care team at their request or at the
request of the treating oncologist. They will complete questionnaires at 12 weeks and 24
weeks after enrollment.
Subjects who are randomized to the Standard Oncology Care with Early Palliative Care will
meet with a palliative care clinician at their next medical oncology visit or infusion
visit. They will meet with the palliative care clinician at least every three weeks. They
will complete questionnaires at 12 and 24 weeks after enrollment.
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Functional Assessment of Cancer Therapy (Quality of life measure)
baseline and 12 weeks
Jennifer Temel, MD
Massachusetts General Hospital
United States: Institutional Review Board
|Massachusetts General Hospital||Boston, Massachusetts 02114-2617|